連帆，女，副主任醫(yī)師，中山大學(xué)附屬醫(yī)院風(fēng)濕免疫科副教授，醫(yī)學(xué)博士，德國Klinikum rechts der Isar醫(yī)院訪問學(xué)者/博士后，長期從事風(fēng)濕免疫性疾病臨床及科研工作，承擔(dān)內(nèi)科特別是風(fēng)濕內(nèi)科專業(yè)本科及研究生教學(xué)工作。主持及參與多項(xiàng)、省級(jí)科研基金，在專業(yè)雜志發(fā)表論著多篇。擅長強(qiáng)直性脊柱炎、銀屑病關(guān)節(jié)炎、類風(fēng)濕關(guān)節(jié)炎、系統(tǒng)性紅斑狼瘡、皮肌炎、干燥綜合征、骨關(guān)節(jié)炎等的診斷和治療。研究方向：1.強(qiáng)直性脊柱炎、類風(fēng)濕關(guān)節(jié)炎等風(fēng)濕免疫疾病的診斷治療2.強(qiáng)直性脊柱炎、類風(fēng)濕關(guān)節(jié)炎等風(fēng)濕免疫疾病的發(fā)病機(jī)理3.強(qiáng)直性脊柱炎、類風(fēng)濕關(guān)節(jié)炎等風(fēng)濕免疫疾病的臨床流行病學(xué)論著：1. Lian F, Xing X, Yuan G, et al. Farnesoid X receptorprotects human and murine gastric epithelial cells against inflammation-induceddamage. Biochem J. 2011 Sep 1;438(2):315-23. (IF=5.01)2. Wang Y,Lian F (co-author), Li JP, et al. Adipose derived mesenchymal stem cellstransplantation via portal vein improves microcirculation and ameliorates liverfibrosis induced by CCl4 inrats. J transl Med. 2012 Jun 26;10. (IF=3.5)3. Lian F, Wang Y, Chen J, et al. Activation offarnesoid X receptor attenuates liver injury in systemic lupus erythematosus.Rheumatol Int. 2012 Jun; 32(6):1705-10. (IF=1.49)4. Lian F, Wang Y, Chen W, Li J, Zhan Z, Ye Y, Zhu Y,Huang J, Xu H, Yang X, Liang L, Yang J. Uterine Artery Embolization Combinedwith Local Methotrexate and Systemic Methotrexate for Treatment of CesareanScar Pregnancy with Different Ultrasonographic Pattern. Cardiovasc InterventRadiol. 2012 Apr; 35(2):286-91. (IF=2.00)5. Lian F, Yang X, Liang L, Xu H, Zhan Z, Qiu Q, YeY. Treatment efficacy by Etanercept and MTX combination therapy of ankylosingspondylitis hip joint lesion in Chinese population. Rheumatol Int. 2012 Jun;32(6):1663-7. (IF=1.49)6. Lian F, Wang Y, Yang X, Xu H,Liang L. Clinical features and hyperferritinemia diagnostic cutoff points forAOSD based on ROC curve: a Chinese experience. Rheumatol Int. 2012 Jan; 32(1):189-92. (IF=1.49)7. Lian F, et al. Clinical featuresand independent predictors of pulmonary arterial hypertension in systemic lupuserythematosus. Rheumatol Int.2012Jun; 32(6): 1727-31. (IF=1.49)所獲得的負(fù)責(zé)人基金：自然科學(xué)基金（青年基金）（2011）負(fù)責(zé)人核受體FXR調(diào)控TEF控制自身免疫性肝炎炎癥過度凋亡的研究廣東省自然科學(xué)基金（博士啟動(dòng)）（2011）負(fù)責(zé)人FXR及其靶基因TEF在自身免疫性肝炎的作用廣東省醫(yī)學(xué)科研基金 （2011）負(fù)責(zé)人核受體FXR及其新靶基因TEF對(duì)自免肝炎癥凋亡影響的研究